These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 36685039)

  • 61. Comparison of serum cytokine levels in symptomatic and asymptomatic HIV-Leishmania coinfected individuals from a Brazilian visceral leishmaniasis endemic area.
    Guedes DL; Silva EDD; Castro MCAB; Júnior WLB; Ibarra-Meneses AV; Tsoumanis A; Adriaensen W; van Griensven J; Pereira VRA; Medeiros ZM
    PLoS Negl Trop Dis; 2022 Jun; 16(6):e0010542. PubMed ID: 35714136
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Liposomal amphotericin B for visceral leishmaniasis in human immunodeficiency virus-coinfected patients: 2-year treatment outcomes in Bihar, India.
    Sinha PK; van Griensven J; Pandey K; Kumar N; Verma N; Mahajan R; Kumar P; Kumar R; Das P; Mitra G; Flevaud L; Ferreyra C; Remartinez D; Pece M; Palma PP
    Clin Infect Dis; 2011 Oct; 53(7):e91-8. PubMed ID: 21890763
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epidemiological patterns of mortality due to visceral leishmaniasis and HIV/AIDS co-infection in Brazil, 2000-2011.
    Martins-Melo FR; Lima Mda S; Alencar CH; Ramos AN; Heukelbach J
    Trans R Soc Trop Med Hyg; 2014 Jun; 108(6):338-47. PubMed ID: 24706340
    [TBL] [Abstract][Full Text] [Related]  

  • 64.
    van Griensven J; Mengesha B; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Vogt F; Adriaensen W; Diro E
    Front Cell Infect Microbiol; 2018; 8():94. PubMed ID: 29651411
    [No Abstract]   [Full Text] [Related]  

  • 65. [Visceral leishmaniasis: a comparative study of patients with and without human immunodeficiency virus infection].
    Reus S; Sánchez R; Portilla J; Boix V; Priego M; Merino E; Román F
    Enferm Infecc Microbiol Clin; 1999 Dec; 17(10):515-20. PubMed ID: 10650648
    [TBL] [Abstract][Full Text] [Related]  

  • 66. High frequency of subclinical Leishmania infection among HIV-infected patients living in the endemic areas of visceral leishmaniasis in Fars province, southern Iran.
    Rezaei Z; Sarkari B; Dehghani M; Layegh Gigloo A; Afrashteh M
    Parasitol Res; 2018 Aug; 117(8):2591-2595. PubMed ID: 29860572
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The immunology of post-kala-azar dermal leishmaniasis (PKDL).
    Zijlstra EE
    Parasit Vectors; 2016 Aug; 9(1):464. PubMed ID: 27553063
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Antigen Detection in Urine for Noninvasive Diagnosis and Treatment Monitoring of Visceral Leishmaniasis in Human Immunodeficiency Virus Coinfected Patients: An Exploratory Analysis from Ethiopia.
    Vogt F; Mengesha B; Asmamaw H; Mekonnen T; Fikre H; Takele Y; Adem E; Mohammed R; Ritmeijer K; Adriaensen W; Melsew Y; van Griensven J; Diro E
    Am J Trop Med Hyg; 2018 Oct; 99(4):957-966. PubMed ID: 30084342
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Visceral leishmaniasis and HIV coinfection in Latin America.
    Lindoso JA; Cota GF; da Cruz AM; Goto H; Maia-Elkhoury AN; Romero GA; de Sousa-Gomes ML; Santos-Oliveira JR; Rabello A
    PLoS Negl Trop Dis; 2014 Sep; 8(9):e3136. PubMed ID: 25233461
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Quantification of parasite load in clinical samples of leishmaniasis patients: IL-10 level correlates with parasite load in visceral leishmaniasis.
    Verma S; Kumar R; Katara GK; Singh LC; Negi NS; Ramesh V; Salotra P
    PLoS One; 2010 Apr; 5(4):e10107. PubMed ID: 20404924
    [TBL] [Abstract][Full Text] [Related]  

  • 71. HIV/AIDS-associated visceral leishmaniasis in patients from an endemic area in Central-west Brazil.
    Alexandrino-de-Oliveira P; Santos-Oliveira JR; Dorval ME; Da-Costa Fd; Pereira GR; da Cunha RV; Paniago AM; Da-Cruz AM
    Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):692-7. PubMed ID: 20835619
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Visceral leishmaniasis in Northeast Brazil: What is the impact of HIV on this protozoan infection?
    Silva de Lima UR; Vanolli L; Moraes EC; Ithamar JS; Azevedo CMPES
    PLoS One; 2019; 14(12):e0225875. PubMed ID: 31805100
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Parasite susceptibility to amphotericin B in failures of treatment for visceral leishmaniasis in patients coinfected with HIV type 1 and Leishmania infantum.
    Lachaud L; Bourgeois N; Plourde M; Leprohon P; Bastien P; Ouellette M
    Clin Infect Dis; 2009 Jan; 48(2):e16-22. PubMed ID: 19093811
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinicoepidemiologic characteristics, prognostic factors, and survival analysis of patients coinfected with human immunodeficiency virus and Leishmania in an area of Madrid, Spain.
    Lopez-Velez R; Perez-Molina JA; Guerrero A; Baquero F; Villarrubia J; Escribano L; Bellas C; Perez-Corral F; Alvar J
    Am J Trop Med Hyg; 1998 Apr; 58(4):436-43. PubMed ID: 9574788
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Relapsing visceral leishmaniasis in HIV-infected patients undergoing successful protease inhibitor therapy.
    Casado JL; Lopez-Velez R; Pintado V; Quereda C; Antela A; Moreno S
    Eur J Clin Microbiol Infect Dis; 2001 Mar; 20(3):202-5. PubMed ID: 11347673
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Immunomodulatory Therapy of Visceral Leishmaniasis in Human Immunodeficiency Virus-Coinfected Patients.
    Adriaensen W; Dorlo TPC; Vanham G; Kestens L; Kaye PM; van Griensven J
    Front Immunol; 2017; 8():1943. PubMed ID: 29375567
    [TBL] [Abstract][Full Text] [Related]  

  • 77. A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia.
    Diro E; Blesson S; Edwards T; Ritmeijer K; Fikre H; Admassu H; Kibret A; Ellis SJ; Bardonneau C; Zijlstra EE; Soipei P; Mutinda B; Omollo R; Kimutai R; Omwalo G; Wasunna M; Tadesse F; Alves F; Strub-Wourgaft N; Hailu A; Alexander N; Alvar J
    PLoS Negl Trop Dis; 2019 Jan; 13(1):e0006988. PubMed ID: 30653490
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Leishmaniases and HIV/AIDS co-infections: review of common features and management experiences.
    Ali A
    Ethiop Med J; 2002 Apr; 40 Suppl 1():37-49. PubMed ID: 12802830
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome.
    Ritmeijer K; Veeken H; Melaku Y; Leal G; Amsalu R; Seaman J; Davidson RN
    Trans R Soc Trop Med Hyg; 2001; 95(6):668-72. PubMed ID: 11816442
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIV.
    Adriaensen W; Cuypers B; Cordero CF; Mengasha B; Blesson S; Cnops L; Kaye PM; Alves F; Diro E; van Griensven J
    EBioMedicine; 2020 May; 55():102748. PubMed ID: 32361248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.